Physically Crosslinked Chondroitin Sulfate (CS)–Metal Ion (M: Fe(III), Gd(III), Zn(II), and Cu(II)) Particles for Versatile Applications and Their Biosafety
-
Published:2023-03-23
Issue:4
Volume:16
Page:483
-
ISSN:1424-8247
-
Container-title:Pharmaceuticals
-
language:en
-
Short-container-title:Pharmaceuticals
Author:
Suner Selin S.1ORCID, Sahiner Mehtap2, Umut Evrim34, Ayyala Ramesh S.5, Sahiner Nurettin156ORCID
Affiliation:
1. Department of Chemistry, Nanoscience and Technology Research and Application Center, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100 Canakkale, Turkey 2. Department of Bioengineering, Engineering Faculty, Canakkale Onsekiz Mart University, 17100 Canakkale, Turkey 3. Department of Medical Imaging Techniques, School of Healthcare, Dokuz Eylul University, 35330 Izmir, Turkey 4. Bioİzmir-Izmir Health Technologies Development and Accelerator Research and Application Center, Dokuz Eylul University, 35330 Izmir, Turkey 5. Department of Ophthalmology, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs B. Downs Blv, MDC 21, Tampa, FL 33612, USA 6. Department of Chemical and Biomolecular Engineering, University of South Florida, Tampa, FL 33620, USA
Abstract
Chondroitin sulfate (CS), a well-known glycosaminoglycan, was physically crosslinked with Fe(III), Gd(III), Zn(II), and Cu(II) ions to obtain CS-Fe(III), CS-Gd(III), CS-Zn(II), and CS-Cu(II) polymeric particles for multipurpose biological applications. The CS–metal ion-containing particles in the micrometer to a few hundred nanometer size range are injectable materials for intravenous administration. The CS–metal ion-containing particles are safe biomaterials for biological applications because of their perfect blood compatibility and no significant cytotoxicity on L929 fibroblast cells up to a 10 mg/mL concentration. Furthermore, CS-Zn(II) and CS-Cu(II) particles show excellent antibacterial susceptibility, with 2.5–5.0 mg/mL minimum inhibition concentration (MIC) values against Escherichia coli and Staphylococcus aureus. Moreover, the in vitro contrast enhancement abilities of aqueous CS–metal ion particle suspensions in magnetic resonance imaging (MRI) were determined by obtaining T1- and T2-weighted MR images using a 0.5 Tesla MRI scanner and by calculating the water proton relaxivities. Therefore, these CS-Fe(III), CS-Gd(III), CS-Zn(II), and CS-Cu(II) particles have significant potential as antibacterial additive materials and MRI contrast enhancement agents with less toxicity.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference42 articles.
1. Vessella, G., Vázquez, J.A., Valcárcel, J., Lagartera, L., Monterrey, D.T., Bastida, A., García-Junceda, E., Bedini, E., Fernández-Mayoralas, A., and Revuelta, J. (2021). Deciphering Structural Determinants in Chondroitin Sulfate Binding to FGF-2: Paving the Way to Enhanced Predictability of Their Biological Functions. Polymers, 13. 2. Awofiranye, A.E., Hudson, J., Tithi, A.D., Linhardt, R.J., Vongsangnak, W., and Koffas, M.A.G. (2022). Chondroitin Sulfate and Its Derivatives: A Review of Microbial and Other Production Methods. Fermentation, 8. 3. Fan, X.-M., Huang, J.-Y., Ling, X.-M., Wei, W., Su, W.-B., and Zhang, Y.-W. (2022). A Highly Active Chondroitin Sulfate Lyase ABC for Enzymatic Depolymerization of Chondroitin Sulfate. Polymers, 14. 4. Santos, G.R.C., Piquet, A., Glauser, B., Tovar, A.M.F., Pereira, M., Vilanova, E., and Mourão, P.A.S. (2017). Systematic Analysis of Pharmaceutical Preparations of Chondroitin Sulfate Combined with Glucosamine. Pharmaceuticals, 10. 5. Chondroitin Sulfate: Emerging biomaterial for biopharmaceutical purpose and tissue engineering;Sharma;Carbohydr. Polym.,2022
|
|